P67 Current practices for prescribing nebulised hypertonic saline in patients with neuromuscular dis...
P67 Current practices for prescribing nebulised hypertonic saline in patients with neuromuscular diseases or cerebral palsy
About this item
Full title
Author / Creator
Galaz-Souza, N , Tan, HL , Hurley, M and Bush, A
Publisher
London: BMJ Publishing Group Ltd and British Thoracic Society
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd and British Thoracic Society
Subjects
More information
Scope and Contents
Contents
IntroductionNebulised hypertonic saline (HS, usually 3%, 6% or 7%) is used to aid airway clearance and reduce respiratory exacerbations in patients with Cystic Fibrosis (CF). Its use is extrapolated from evidence in patients with CF to those with Neuromuscular Disease (NMD) and Cerebral Palsy (CP), with only retrospective evidence showing a signifi...
Alternative Titles
Full title
P67 Current practices for prescribing nebulised hypertonic saline in patients with neuromuscular diseases or cerebral palsy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2889414941
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2889414941
Other Identifiers
ISSN
0040-6376
E-ISSN
1468-3296
DOI
10.1136/thorax-2023-BTSabstracts.219
